Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 1977 - 1984 of 12008 results
Newly Enacted Federal “Speak Out Act” Limits Use of Some Sexual Harassment NDAs
December 9, 2022| Blog| Viewpoint
Partnering and Giving Back With Clinic in a Box®
December 8, 2022| Article| Viewpoint
From the Edge - In the Boardroom: Session 6 - Crises in the Boardroom
December 7, 2022| Podcast| Viewpoint
MintzTech Connect: All Things Technology — December 2022
December 7, 2022| Article| Viewpoint
MintzTech Connect Industry News: Spotlight on Ben Zises and SuperAngel.Fund
December 7, 2022| Article| Viewpoint
Is Your Website Collecting PHI Under OCR's New Tracking Technologies Bulletin?
December 7, 2022| Blog| Viewpoint
Preparation for 2022 Fiscal Year-End SEC Filings and 2023 Annual Shareholder Meetings
December 7, 2022| Advisory| Viewpoint
No Uncertain Terms - What 2023 Has in Store for M&A Activity, Valuations and Deal Terms
December 7, 2022| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|